Brentuximab-5014: Brentuximab Vedotin Administration Registry and Outcomes Study in Polish CTCL Patients (BV-BALTIC study)

06/10/2020
10/12/2025
EU PAS number:
EUPAS36934
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Brentuximab-5014-clinical-study-protocol-redact (1).pdf

English (1.03 MB - PDF) View document
Updated protocol

Brentuximab-5014-clinical-study-protocol-redact.pdf

First published: 02/12/2025
English (4.44 MB - PDF) View document
Study results
Study results

Brentuximab-5014-clinical-study-report-redact.pdf

English (1.19 MB - PDF) View document
Study report
Other information